Sandoz launches generic lenalidomide in 19 countries across Europe, expanding access to essential oncology medicine
Lenalidomide Sandoz is indicated for use in several critical haematology-oncology conditions, per latest ESMO guidelines1,4…
News
PCI Biotech fourth quarter and preliminary full year 2021 results
Oslo (Norway), 18 February 2022 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company,…
Santhera Completes Repayment of 2017/22 Convertible Bonds
Pratteln, Switzerland, February 18, 2022 – Santhera Pharmaceuticals (SIX: SANN) announces full redemption of its senior…
Update on ongoing DupixentĀ® (dupilumab) chronic spontaneous urticaria Phase 3 program
Update on ongoing Dupixent® (dupilumab) chronic spontaneous urticaria Phase 3 program In a Phase 3…
Blue Water Vaccines Announces Pricing of approximate $20M Initial Public Offering
CINCINNATI, Feb. 17, 2022 (GLOBE NEWSWIRE) — Blue Water Vaccines, Inc. (“BWV” or “Blue Water…
ConocoPhillips Completes Purchase of Additional 10% Shareholding Interest in APLNG
HOUSTON–(BUSINESS WIRE)–ConocoPhillips (NYSE: COP) today announced through its Australian subsidiary that it has completed the…
Intel Highlights 2022 and Long-Term Growth Strategy at Investor Meeting
Intel details plans to lead in traditional markets, disrupt high-growth emerging markets. SAN FRANCISCO–(BUSINESS WIRE)–Intel…
Modular Devices Holdings, LLC Expands Executive Team, Hires Sarah Robison as Chief Financial Officer
INDIANAPOLIS–(BUSINESS WIRE)–Modular Devices Holdings, LLC (“Modular Devices”), a leading provider of mobile and modular medical…
BioAegis Therapeutics Announces Appointment of Two New Corporate Board Members
New board members bring a wealth of financial, strategy and global health expertise NORTH BRUNSWICK,…
Galecto Reports Financial Results for the Year Ended December 31, 2021
Continued pipeline progress with three potentially first-in-class product candidates Strong cash position with cash runway…
Orionās collaboration partner Bayer upgrades estimate on NubeqaĀ®ās peak sales potential
ORION CORPORATION INSIDE INFORMATION / STOCK EXCHANGE RELEASE 17 FEBRUARY 2022 at 23.32 EET Orion’s…
Darolutamide plus androgen deprivation therapy and docetaxel significantly increases overall survival in patients with metastatic hormone-sensitive prostate cancer
ORION CORPORATION PRESS RELEASE17 FEBRUARY 2022 at 23.32 EET Darolutamide plus androgen deprivation therapy and docetaxel…
Cronos Group Inc. to Hold 2021 Third Quarter Earnings Conference Call on February 18, 2022
TORONTO, Feb. 17, 2022 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos…
NexImmuneĀ Appoints Kristi Jones as Chief Executive Officer and Member of the Board of Directors
Ms. Jones, a veteran of the biotechnology and pharmaceutical industries, has served as an Executive Officer…
Genesis Unicorn Capital Corp. Announces Closing of Initial Public Offering and Exercise of Full Over-Allotment Option
Princeton, NJ, Feb. 17, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Genesis Unicorn Capital Corp. (the “Company”)…
Shockwave Medical Reports Fourth Quarter and Full Year 2021 Financial Results
SANTA CLARA, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (Nasdaq: SWAV), a…
T2 Biosystems Announces Fourth Quarter & Full Year 2021 Financial Results
Full Year 2021 Total Revenue Growth of 55%; Plans to Double Sepsis Revenue and T2Dx…
Relay Therapeutics to Announce Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights
CAMBRIDGE, Mass., Feb. 17, 2022 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage…
Organogenesis Appoints Michael J. Driscoll, Ed.D. to Board of Directors
CANTON, Mass., Feb. 17, 2022 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading…
Bioasis Announces $200,000 Non-Brokered Private Placement
NEW HAVEN, Conn., Feb. 17, 2022 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the…